Kodiak Sciences stock soars on positive AMD trial data
Investing.com — Kodiak Sciences Inc (NASDAQ:KOD) shares surged as much as 90% in premarket trading Monday following positive…
This Biotech Company Added Nearly $3B To Its Market Cap – Here’s Why KOD Stock Is Ripping Today
Zenkuda and Tabirafusp-ted produced vision improvements that were statistically non-inferior to Aflibercept, an established treatment for the eye…
Mounjaro’s Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib
The FDA expanded the indication for tirzepatide (Mounjaro) to include reducing the risk of major adverse cardiovascular events…
EyePoint’s Duravyu falls short to Eylea in Phase III trial
EyePoint’s stock dropped 67% after its potential Eylea (aflibercept) competitor Duravyu fell short in a Phase III trial…
5 ways to preserve your vision as you age, according to an ophthalmologist
As people age, vision naturally declines and the risk of eye conditions increases. That includes age-related macular degeneration…
Human Stem Cell Transplants Boost Vision in Advanced Dry AMD
Summary: A new clinical trial suggests stem cell therapy may restore vision in people with advanced dry age-related…